Lindus Health Ltd.

https://www.lindushealth.com

LinkedIn: https://www.linkedin.com/company/lindushealth

Lindus Health is a London-based start-up with teams in the UK, US and Germany that runs clinical trials three times faster than the old-fashioned industry-standard – bringing ground-breaking treatments to patients more quickly. Clinical trials are the biggest bottleneck to advances in healthcare and by removing this constraint Lindus Health aim’s to improve health for everyone. Lindus does this by marring a world-class clinical operations team with its pioneering software platform that can manage a trial from start to finish. From monitoring trial data in real-time to using machine learning to predict trial outcomes and make improvements to trial designs in advance, Lindus is simplifying and accelerating the trial process and putting patients first. Lindus Health has to date delivered more than 80 trials across the UK, US and Europe to tackle a range of conditions including diabetes, asthma, acne, social anxiety, major depressive disorder, hypertension, chronic fatigue syndrome and insomnia. The company was named for James Lind, who pioneered the first clinical trial and treatment for scurvy, and was co-founded by Michael Young, a former No 10 Special Adviser on Life Sciences, and Meri Beckwith, a former Venture Capitalist focused on Life Sciences. *

	Start	2021-03-29 established
	Industry	contract research (drugs)
	Industry 2	clinical research services
	Person	Young, Michael (Lindus Health 202308 Co-Founder)
	Person 2	Beckwith, Meri (Lindus Health 202308 Co-Founder)

	Region	London, Greater London
	Country	United Kingdom (GB)
	Street	Weston Street The Leather Market, Unit A, Bermondsey
	City	SE1 3ER London
		Address record changed: 2024-01-05

Basic data	Employees	B: 11 to 50 (2023-08-16)

		* Document for »About Section«: Lindus Health Ltd.. (8/16/23). "Press Release: Announcing Our $18m Series A Led by Investors Creandum and with Participation from Peter Thiel". London.

		Record changed: 2023-08-24